Genmab A/S (GNMSF)
330.37
-5.88
(-1.75%)
USD |
OTCM |
Jan 16, 16:00
Genmab Market Cap: 20.35B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 269.61B |
| Ascendis Pharma A/S | 13.14B |
| Evaxion AS | 29.56M |
| IO Biotech, Inc. | 37.10M |
Market Cap Related Metrics
| PE Ratio | 14.06 |
| PS Ratio | 5.796 |
| PEG Ratio | 0.1112 |
| Price to Book Value | 3.539 |
| Price to Free Cash Flow | 17.03 |
| Price | 330.37 |
| Earnings Yield | 7.11% |
| PEGY Ratio | 0.1112 |
| Operating PE Ratio | 15.73 |
| Normalized PE Ratio | 13.99 |